Range
0.29 - 0.33
Vol / Avg.
72.1K/21.3K
Div / Yield
-
52 Wk
0.12 - 0.38
Mkt Cap
21.8M
Payout Ratio
-
Open
0.29
P/E
36.77
EPS
0.01
Shares
71.8M
Outstanding
-
Total Float
-
There is no Press for this Ticker
Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological disease and disorders. The company has worked on blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, p97, and components thereof, to deliver therapeutics across the blood-brain barrier. Its source of revenue involves the research and license revenue.

Related Companies

TickerCompanyChg %Mkt Cap
BIOAFBioasis Technologies6.49%21.8M

Bioasis Technologies Frequently Asked Questions

Q

How do I buy Bioasis Technologies (BIOAF) stock?

A

You can purchase shares of Bioasis Technologies (OTC: BIOAF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Bioasis Technologies's (BIOAF) competitors?

A

There are no as such competitors for Bioasis Technologies.

Q

What is the target price for Bioasis Technologies (BIOAF) stock?

A

There is no analysis for Bioasis Technologies

Q

Current Stock Price for Bioasis Technologies (BIOAF)?

A

The stock price for Bioasis Technologies (OTC: BIOAF) is $0.3035 last updated Fri Jun 11 2021 19:53:15 GMT+0000 (Coordinated Universal Time).

Q

Does Bioasis Technologies (BIOAF) pay a dividend?

A

There are no upcoming dividends for Bioasis Technologies.

Q

When is Bioasis Technologies (OTC:BIOAF) reporting earnings?

A

Bioasis Technologies does not have any upcoming earnings scheduled.

Q

Is Bioasis Technologies (BIOAF) going to split?

A

There is no upcoming split for Bioasis Technologies.

Q

What sector and industry does Bioasis Technologies (BIOAF) operate in?

A

Bioasis Technologies is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the OTC.